Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-12-31

Clinical Trial Update: The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy [NA]

View source ↗

Summary

Clinical trial update evaluating oral and IV Ramosetron to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramosetron (ramosetron)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Nausea, Vomiting | NA | Status: UNKNOWN